<DOC>
	<DOC>NCT01529034</DOC>
	<brief_summary>The purpose of this study is to examine the long-term safety and tolerability of USL261 in the treatment of seizure clusters.</brief_summary>
	<brief_title>Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Has a competent, adult caregiver who can recognize and observe the subject's seizure cluster episodes Has successfully completed study P261401, and the subject and caregiver have demonstrated adequate compliance with P261401 study procedures as determined by the investigator Has experienced status epilepticus during or since the P261401 study In the opinion of the investigator, is experiencing an ongoing, uncontrolled, clinically significant adverse event(s) from P261401 at Visit 1 or did experience a clinically significant adverse event in study P261401 that might prevent the subject from safely participating in the study Has a neurological disorder that is likely to progress in the next year Has a history of acute narrowangle glaucoma Has a medical condition including uncontrolled cardiac, pulmonary, renal, hepatic, or gastrointestinal disease that could interfere with the study, subject safety/safety monitoring, or is not stable despite current therapy Subject has severe chronic cardiorespiratory disease or the need for ambulatory oxygen Has had psychogenic, nonepileptic seizure(s) during or since the P261401 study Has active suicidal plan or intent as determined by the CSSRS at Visit 1 or medical history Subject has had vagus nerve stimulator (VNS) implanted since the completion of study P261401</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>seizure clusters</keyword>
	<keyword>acute repetitive seizures</keyword>
	<keyword>rescue treatment</keyword>
</DOC>